[Interview] Zuo Quan talks about the development of ALD Group: Taking compliance as the cornerstone, sticking to the innovative development strategy

MarketInnovation
Jun.23.2022
[Interview] Zuo Quan talks about the development of ALD Group: Taking compliance as the cornerstone, sticking to the innovative development strategy
2FIRSTS was able to interview Zuo Quan and he described the company's initial start: "Before the company was founded, it had already accumulated a lot of experience in the field of electronic cigarettes, and also some customer resources at home and abroad. The establishment of the company can be regarded as a natural process driven by the market."

On June 15, 2022, the "2022 6th E-Cigarette Industry Standard and Compliance Conference and the E-Cigarette Export Trade Development Conference" hosted by the ECCC was held in Shenzhen Baoan, JW Marriott Hotel. During the conference, 2FIRSTS was able to interview Zuo Quan and he described the company's initial start: "Before the company was founded, it had already accumulated a lot of experience in the field of electronic cigarettes, and also some customer resources at home and abroad. The establishment of the company can be regarded as a natural process driven by the market."

 

A foundation in experience and customer resources, market-driven, and natural path- these keywords may be difficult to think of as the reason for the establishment of a business. The director and co-founder of ALD Group proudly terms them "Versailles".

 

On June 15, 2022, the "2022 6th E-Cigarette Industry Standard and Compliance Conference and the E-Cigarette Export Trade Development Conference" hosted by the ECCC was held in Shenzhen Baoan, JW Marriott Hotel. During the conference, 2FIRSTS was able to interview Zuo Quan and he described the company's initial start: "Before the company was founded, it had already accumulated a lot of experience in the field of electronic cigarettes, and also some customer resources at home and abroad. The establishment of the company can be regarded as a natural process driven by the market."

 

Technology is the Primary Productive Forces

 

ALD Group is located in Bao'an District, Shenzhen. It is a vaporization technology company specializing in the manufacturing of electronic products. Since the establishment of the company in 2009, it has been more than 12 years since the company entered the trade. The company has always adhered to the development principle of "technology is the primary productive force". During the interview, we learned that in order to improve the production level and R&D capability of the company, ALD has established a close R&D cooperation relationship with domestic universities. They include the establishment of a research center with the School of Chemical Engineering of Sun Yat-Sen University

 

Zuo Quan said: "The company currently has a strong R&D and business development team. We also have deep accumulation in advanced intelligence and automation manufacturing capabilities. The R&D cooperation with various domestic universities is mainly in safety compliance, environmental protection materials, and user experience. These aspects are important to help the healthy development of the company. It also helps the strategic development direction of the entire company.”

 

Facing the Challenge Head on, Compliance is the Cornerstone

 

Although the development of ALD Group is "successful", it was not "smooth". As an emerging industry, in the process of internationalization facing some regions with unclear regulations, the product export still faces huge policy barriers.

 

With the vigorous development of the e-cigarette industry in recent years, many newcomers have been pouring in, bringing new vitality to the market, but also causing negative phenomenon such as infringement of intellectual property rights and price wars. "This is very harmful to enterprises as well as the entire industry. Due to the relatively short development time of the industry, the market also has large fluctuations." Zuo Quan said.

 

At this conference, Zuo Quan, emphasized in an exclusive interview with reporters that no matter how much the market fluctuates, ALD Group will face difficulties with a positive attitude. Talking about the core point of future development, he affirmed: "The company has always stuck to the focus of innovation in face of future development. Before that, compliance is of course the foundation of everything."

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives